Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)

开环异落叶松树脂醇二葡萄糖苷 (SDG) 抑制间皮瘤

基本信息

项目摘要

DESCRIPTION (provided by applicant): Despite worldwide banning of asbestos use, domestic and environmental exposure to asbestos unfortunately persists. Exposure to asbestos fibers has been linked to the development of malignant mesothelioma (MM) and lung cancer (LC); however, the pathogenesis of asbestos-related diseases is complicated and still poorly understood. Pulmonary inflammation related to asbestos exposure has been shown in both animal models and humans. Additional studies revealed that asbestos fibers generate reactive oxygen and nitrogen species (ROS/RNS) and cause oxidation and/or nitrosylation of proteins and DNA. In addition to damaging macromolecules, such oxidants play important roles in the initiation of numerous signal transduction pathways that are linked to apoptosis, inflammation, and proliferation. Unfortunately, while asbestos-exposed individuals are offered medical surveillance or financial compensation, but nothing is currently being undertaken to decrease their cancer risk. In fact the long latency of asbestos-related cancers ranging from 10 years for LC and up to 50 years for MM, allows a wide window for chemopreventive strategies to be used whereby one can intervene with natural or synthetic agents to intercept or prevent malignant transformation due to exposure. Remarkably, nothing is currently being done to lower cancer risk to asbestos-exposed individuals and the scarcity of clinical trials in this area underscores the unmet need for intervention. Our group has evaluated wholegrain flaxseed in murine models of oxidative lung damage such as radiation toxicity and attributed its tissue protective properties mainly to the antioxidant, anti-inflammatory and anti-fibrotic effects of its lignan component. The predominant bioactive lignan in flax seed is Secoisolariciresinol Diglucoside (SDG), a biphenolic agent. Importantly, SDG-supplemented diets robustly mitigated radiation toxicity manifested as chronic inflammation, oxidative tissue damage and fibrosis when administered to mice long after the initial radiation insult occurred. We therefore, hypothesize that SDG will similarly abrogate asbestos toxicity by interfering with initiation and propagation of ongoing damaging processes that would ultimately lead to lung fibrosis, chronic inflammation and oxidative tissue damage, conditions found to be linked to MM development. To test this, we designed two Aims whereby the action of SDG in 2 mouse models of asbestos-induced MM will be evaluated. In Specific Aim 1 we will test anti-inflammatory effects of flaxseed and SDG lignan diets in the SV40 TAg and the NF2 +/- mouse model of asbestos-inflammation and in Specific Aim 2 we will test the cancer chemopreventive effects in blunting MM formation and boosting survival. If our intervention proves effective in inhibiting inflammation, delaying the onset of malignancy or decreasing tumor burden in any of the models, we will pursue mechanistic studies to evaluate SDG in asbestos-exposed mesothelial cells and macrophages for inflammasome activation, apoptosis, DNA damage, ROS/RNS generation and signaling pathway activation (Fos and Jun families).
描述(由申请人提供):尽管全世界禁止使用石棉,但不幸的是,国内和环境暴露于石棉。接触石棉纤维与恶性间皮瘤(MM)和肺癌(LC)的发展有关。然而,与石棉相关疾病的发病机理是复杂的,并且仍然很了解。在动物模型和人类中都显示了与石棉暴露有关的肺部炎症。其他研究表明,石棉纤维产生活性氧和氮种(ROS/RN),并引起蛋白质和DNA的氧化和/或硝基化。除了破坏大分子外,这种氧化剂在启动许多与凋亡,炎症和增殖有关的信号转导途径的启动中起着重要作用。不幸的是,虽然向石棉暴露的人提供医疗监视或经济补偿,但目前没有采取任何措施来降低其癌症风险。实际上,与石棉相关的癌症的较长潜伏期从LC的10年到50年的MM不等,可以使用宽阔的窗口,以便使用化学预防策略的窗口,从而可以介入自然或合成剂拦截或防止因暴露而导致的恶性转化。值得注意的是,目前没有采取任何措施来降低对石棉暴露的个体的癌症风险,并且该领域的临床试验稀缺强调了对干预的未满足需求。我们的小组在氧化性肺损伤的鼠模型中评估了全格兰亚麻籽,例如辐射毒性,并归因于其组织保护特性 主要针对其木质胶成分的抗氧化剂,抗炎和抗纤维化作用。这 亚麻种子中的主要生物活性木质激素是双苯酚剂二糖尿甲醇(SDG)。重要的是,在初始辐射损伤发生后很长一段时间后,当对小鼠施用时,可加强可持续发展可靠的饮食可降低辐射毒性,表现为慢性炎症,氧化组织损伤和纤维化。因此,我们假设可持续发展目标将通过干扰正在进行的损害过程的起始和传播来消除石棉毒性,这些过程最终会导致肺纤维化,慢性炎症和氧化组织损伤,发现与MM发育有关。为了测试这一点,我们设计了两个目标,可以评估可持续发展目标在2个小鼠诱导的MM鼠标模型中的作用。在特定目的1中,我们将测试SV40标签中亚麻籽和可持续发展木质饮食的抗炎作用,以及石棉-Inflammation的NF2 +/-小鼠模型,在特定目标2中,我们将测试癌症化学预防效应在MM形成和增强MM形成和增强生存中的癌症化学预防作用。如果我们的干预措施在抑制炎症,延迟恶性肿瘤或减轻肿瘤负担的任何模型中有效,我们将进行机械研究,以评估石棉暴露的间皮细胞和巨噬细胞中的可持续发展疾病,以及炎性症的炎症,proptistoration,proptoctoration,proptositation,DNA损害,DNA损害,ROS/RNS的产生和信号path和信号激活(FOS)和信号激活(FOS)(FOS)和信号激活(OS)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Melpo Christofidou-Solomidou其他文献

Melpo Christofidou-Solomidou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Melpo Christofidou-Solomidou', 18)}}的其他基金

NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION
治疗创伤引起的炎症的新型合成 SDG
  • 批准号:
    8984869
  • 财政年份:
    2015
  • 资助金额:
    $ 6.96万
  • 项目类别:
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION
治疗创伤引起的炎症的新型合成 SDG
  • 批准号:
    8824322
  • 财政年份:
    2015
  • 资助金额:
    $ 6.96万
  • 项目类别:
Piperlongumine as a Novel Radiosensitizer for Lung Cancer
Piperlongumine 作为肺癌的新型放射增敏剂
  • 批准号:
    9017962
  • 财政年份:
    2015
  • 资助金额:
    $ 6.96万
  • 项目类别:
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)
开环异落叶松树脂醇二葡萄糖苷 (SDG) 抑制间皮瘤
  • 批准号:
    8695307
  • 财政年份:
    2013
  • 资助金额:
    $ 6.96万
  • 项目类别:
Mitigation of Radiation Pneumonopathy By Lignan Action
通过木酚素作用缓解放射性肺炎
  • 批准号:
    7586002
  • 财政年份:
    2010
  • 资助金额:
    $ 6.96万
  • 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
  • 批准号:
    8501743
  • 财政年份:
    2008
  • 资助金额:
    $ 6.96万
  • 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
  • 批准号:
    7895840
  • 财政年份:
    2008
  • 资助金额:
    $ 6.96万
  • 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
  • 批准号:
    7693716
  • 财政年份:
    2008
  • 资助金额:
    $ 6.96万
  • 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
  • 批准号:
    8103929
  • 财政年份:
    2008
  • 资助金额:
    $ 6.96万
  • 项目类别:
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy
开环异落叶松树脂醇二葡萄糖苷 (SDB) 对放射性肺病的保护作用
  • 批准号:
    8307407
  • 财政年份:
    2008
  • 资助金额:
    $ 6.96万
  • 项目类别:

相似国自然基金

丙酮酸羧化酶乳酸化修饰介导TCA回补途径调控肺泡巨噬细胞极化在脓毒症ARDS中的机制研究
  • 批准号:
    82300100
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
骨肉瘤细胞通过分泌蛋白SMOC1诱导肺泡巨噬细胞极化促进其肺转移的作用及其机制
  • 批准号:
    82373026
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
肺泡巨噬细胞嘌呤代谢紊乱介导重症肺炎发病的作用机制研究
  • 批准号:
    82370010
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
铜绿假单胞菌分泌蛋白PA3125通过诱导肺泡巨噬细胞PKM2甲基化修饰抑制抗原提呈的机制研究
  • 批准号:
    82370014
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
  • 批准号:
    10665348
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
  • 批准号:
    10725702
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a
利用 CNP-miR146a 靶向炎症和氧化应激治疗急性肺损伤
  • 批准号:
    10382076
  • 财政年份:
    2022
  • 资助金额:
    $ 6.96万
  • 项目类别:
Cellular and molecular mechanisms of e-cigarette vaping-induced acute lung injury
电子烟引起急性肺损伤的细胞和分子机制
  • 批准号:
    10690279
  • 财政年份:
    2022
  • 资助金额:
    $ 6.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了